Site name unknown - Lille Cedex

Site:	Site name unknown - Lille Cedex
Address:
City:	Lille Cedex
State:
Zip:	59020
Country:	France

Phase	Trial	Trial Status [desc]	Site Status	Drug	NCT#
2	Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib (DoviGIST)	Completed	Active	Dovitinib	NCT01478373